Kornberg Roger D.
Related Filers (4)
- Xenetic Biosciences, Inc. (9)
- Cocrystal Pharma, Inc. (6)
- Protalix BioTherapeutics, Inc. (2)
- OphthaliX, Inc. (1)
- Show More ...
Ownership (18)
4
Friday, 12/8/2023
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 7/20/2023
Cocrystal Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/9/2022
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 8/3/2022
Cocrystal Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 12/9/2021
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 7/20/2021
Cocrystal Pharma, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/8/2020
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/24/2020
Cocrystal Pharma, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 4/27/2020
Cocrystal Pharma, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 12/6/2019
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/30/2018
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 11/17/2017
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/23/2016
Xenetic Biosciences, Inc.: Statement of changes in beneficial ownership of securities
3
Monday, 11/21/2016
Xenetic Biosciences, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 3/17/2014
BIOZONE PHARMACEUTICALS, INC.: Initial statement of beneficial ownership of securities
3
Tuesday, 6/11/2013
OphthaliX, Inc.: Initial statement of beneficial ownership of securities
3
Monday, 9/8/2008
Protalix BioTherapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Monday, 9/8/2008
Protalix BioTherapeutics, Inc.: Statement of changes in beneficial ownership of securities